Proliferative exhausted CD8
CDK4 inhibitor
cancer biology
head and neck squamous cell carcinoma
human
human papillomavirus
immunology
inflammation
proliferative exhausted CD8+ T cells
tumor microenvironment
Journal
eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614
Informations de publication
Date de publication:
22 02 2023
22 02 2023
Historique:
received:
14
08
2022
accepted:
01
02
2023
entrez:
22
2
2023
pubmed:
23
2
2023
medline:
25
2
2023
Statut:
epublish
Résumé
The survival prognosis of human papillomavirus (HPV)-positive and HPV-negative head and neck squamous cell carcinoma (HNSCC) is largely different, and little is known about the anti-tumor mechanism of tumor-infiltrated exhausted CD8
Identifiants
pubmed: 36811599
doi: 10.7554/eLife.82705
pii: 82705
pmc: PMC9946444
doi:
pii:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023, Cheng, Qiu, Rao et al.
Déclaration de conflit d'intérêts
DC, KQ, YR, MM, LL, YW, YS, JC, XY, XS, SH, YZ, XC, SW, SY, JL, HW, XP, DL, LY, LC, ZY, YZ, MZ, BY, XZ, WZ, WX, GL, FC, HY, YZ, JR No competing interests declared
Références
Genome Med. 2020 Feb 28;12(1):22
pubmed: 32111241
Cell. 2018 Aug 23;174(5):1293-1308.e36
pubmed: 29961579
Int Rev Cell Mol Biol. 2018;341:63-124
pubmed: 30262035
Clin Cancer Res. 2020 Jun 1;26(11):2693-2703
pubmed: 31932491
Exp Mol Med. 2020 May;52(5):750-761
pubmed: 32439954
Cancer Cell. 2020 Apr 13;37(4):514-529
pubmed: 32289274
Nat Commun. 2017 Jan 16;8:14049
pubmed: 28091601
Front Immunol. 2018 Mar 28;9:635
pubmed: 29643856
Bioinformatics. 2021 Jan 18;:
pubmed: 33459785
Lancet Oncol. 2019 Sep;20(9):1295-1305
pubmed: 31351869
J Nutr. 2013 Jun;143(6):931-3
pubmed: 23616517
Bioinformatics. 2016 Apr 15;32(8):1241-3
pubmed: 26668002
Mol Cell. 2020 Oct 15;80(2):183-192
pubmed: 32946743
J Pathol. 2017 Nov;243(3):354-365
pubmed: 28771750
Oral Oncol. 2021 Mar;114:105164
pubmed: 33465681
Nat Commun. 2021 May 13;12(1):2782
pubmed: 33986293
Innovation (Camb). 2021 Jul 01;2(3):100141
pubmed: 34557778
Cancer Res. 2017 Nov 1;77(21):e108-e110
pubmed: 29092952
Arch Otolaryngol Head Neck Surg. 2010 Dec;136(12):1267-73
pubmed: 21173378
Trends Cell Biol. 2018 Nov;28(11):911-925
pubmed: 30061045
Cell Rep. 2020 Apr 14;31(2):107504
pubmed: 32294430
Nat Immunol. 2019 Mar;20(3):326-336
pubmed: 30778252
Immune Netw. 2020 Feb 20;20(1):e2
pubmed: 32158590
Cell Death Dis. 2019 Nov 14;10(11):867
pubmed: 31727874
J Intern Med. 2020 Feb;287(2):134-152
pubmed: 31733108
Front Public Health. 2020 Oct 30;8:584964
pubmed: 33194991
Nat Methods. 2019 Dec;16(12):1289-1296
pubmed: 31740819
Cell. 2021 Jun 24;184(13):3573-3587.e29
pubmed: 34062119
Oncoimmunology. 2018 Jul 30;7(10):e1498439
pubmed: 30288365
J Hematol Oncol. 2020 May 1;13(1):41
pubmed: 32357912
Nat Immunol. 2020 Dec;21(12):1552-1562
pubmed: 33046887
Nat Methods. 2017 Nov;14(11):1083-1086
pubmed: 28991892
F1000Res. 2020 Jan 27;9:47
pubmed: 32789006
Nat Commun. 2021 Feb 17;12(1):1088
pubmed: 33597522
Front Immunol. 2018 Sep 25;9:2144
pubmed: 30319613
N Engl J Med. 2010 Jul 1;363(1):24-35
pubmed: 20530316
Cancer Res. 2017 Nov 15;77(22):6353-6364
pubmed: 28904066
Int J Cancer. 2019 Apr 15;144(8):1941-1953
pubmed: 30350310
Nature. 2019 Dec;576(7787):465-470
pubmed: 31827286
Cancer Discov. 2018 Feb;8(2):216-233
pubmed: 29101163
Cancer Microenviron. 2013 Aug;6(2):147-57
pubmed: 23104434
Nat Rev Immunol. 2015 Aug;15(8):486-99
pubmed: 26205583
Curr Opin Oncol. 2019 May;31(3):122-130
pubmed: 30986809
Immunity. 2020 May 19;52(5):825-841.e8
pubmed: 32396847
Nat Immunol. 2019 Jul;20(7):890-901
pubmed: 31209400
Nature. 2016 Sep 15;537(7620):417-421
pubmed: 27501248
Nature. 2019 Feb;566(7745):496-502
pubmed: 30787437
Cell. 2017 Dec 14;171(7):1611-1624.e24
pubmed: 29198524
Nat Rev Immunol. 2019 Nov;19(11):665-674
pubmed: 31570879
Sci Rep. 2019 Sep 16;9(1):13404
pubmed: 31527697
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Nat Rev Mol Cell Biol. 2013 Aug;14(8):518-28
pubmed: 23877564